Annovis Bio Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2010 | 2011 | 2012 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -4.7% | -86.5% | -87.4% | -85.8% | +2,090.7% | +626.8% | +466.6% | -21.7% | -71.7% | +36.4% | +51.4% | |
| – | +0.2% | -87.8% | -77.5% | -85.8% | +1,365.9% | +986.2% | +466.6% | -21.7% | -71.7% | +36.4% | +51.4% | |
| – | -68.4% | -94.8% | +380.5% | -89.8% | -94.7% | +434,488.7% | +465.8% | -37.9% | -79.7% | +83.4% | +85.1% | |
| – | – | – | – | -89.8% | -94.7% | +434,488.7% | +465.8% | -37.9% | -79.7% | +83.4% | +85.1% | |
| – | +50.9% | -70.8% | – | – | – | – | – | – | – | – | – | |
| – | +16.9% | -99.6% | – | – | – | – | – | – | – | – | – | |
| – | -18.4% | -89.8% | – | – | – | – | – | – | – | – | – | |
| – | -33.1% | – | – | – | – | – | – | – | – | – | – | |
| – | +40.2% | -30.5% | – | – | – | – | – | – | – | – | – | |
| – | +27.6% | -97.5% | +4,100.2% | +4.4% | +26.8% | -94.0% | +160.5% | +411.0% | +133.3% | -74.3% | -8.4% | |
| – | +27.6% | -97.5% | +181.1% | +15.9% | +254.0% | -71.2% | +160.5% | +411.0% | -44.4% | -9.3% | -6.3% | |
| – | +33.9% | -97.5% | -59.2% | -3.8% | +1,703.3% | -72.3% | +101.3% | +475.7% | -67.4% | +78.4% | +12.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -15.6% | -80.9% | -361.8% | – | – | – | +490.0% | -36.3% | -127.4% | – | +81.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | +0.0% | +0.4% | -7.8% | +20.9% | +7.0% | +10.5% | +35.6% | +68.0% |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.